Immediate Impact
4 by Nobel laureates 52 standout
Citing Papers
Endothelial dysfunction: molecular mechanisms and clinical implications
2024 Standout
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
2023 Standout
Works of Michael Curtis being referenced
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Curtis | 134 | 132 | 51 | 144 | 19 | 329 | |
| Nondita Sarkar | 87 | 162 | 91 | 99 | 16 | 296 | |
| Marcus Vinícius Simões | 118 | 121 | 59 | 66 | 21 | 355 | |
| Richard W. D. Gilbert | 128 | 52 | 15 | 70 | 16 | 318 | |
| Isaac Tea | 64 | 111 | 15 | 195 | 13 | 371 | |
| Lijun Qian | 83 | 73 | 40 | 93 | 23 | 296 | |
| Yean‐Teng Lim | 162 | 179 | 82 | 70 | 22 | 295 | |
| Gregory H. Botz | 28 | 81 | 107 | 106 | 17 | 291 | |
| Susan Schachtner | 138 | 42 | 8 | 178 | 19 | 346 | |
| Sai Prasad | 130 | 164 | 38 | 35 | 18 | 309 | |
| Katharina Wassilew | 110 | 97 | 35 | 76 | 26 | 268 |
All Works
Login with ORCID to disown or claim papers
Loading papers...